Search Results - "CHEMORADIOTHERAPY"

Real-world evidence for preoperative use of (chemo)radiotherapy with intensity modulation for locally advanced rectal cancer by the Colib French group.

Pointreau Y; Centre Jean-Bernard, Le Mans, France. Electronic address: y.pointreau@ilcgroupe.fr., Blanchard N; Groupe médical les Dentellières, Valenciennes, France., Chamois J; Centre hospitalier privé Saint-Grégoire, Rennes, France., Debelleix C; Clinique Tivoli, Bordeaux, France., Gross E; Hôpital privé Clairval, Marseille, France., Hémery CG; Polyclinique de Courlancy, Reims, France., Passerat V; Centre Bayard, Lyon, France., Schipman B; Institut de cancérologie de Bourgogne, Dijon, France.

Journal Article , 2025

Optimal timing of surgery after neoadjuvant chemoradiotherapy in rectal cancer: A retrospective analysis.

Ahmadinejad M; Department of Surgery, School of Medicine, Alborz University of Medical Science, Karaj, Iran. Electronic address: md.m.ahmadinejad@gmail.com., Parvizi A; Radiation Oncology, Independent Practice, Karaj, Iran. Electronic address: parviziarash@gmail.com., Sheikhi S; Department of Surgery, School of Medicine, Alborz University of Medical Science, Karaj, Iran. Electronic address: S.sheikhi@abzums.ac.ir., Eghbal F; Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: fatemeheghbal7@gmail.com., Navabian S; General Practitioner, Independent Practice, Karaj, Iran. Electronic address: Susan.navabian@yahoo.com., Chaboki F; Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: Faranak.chaboki97@gmail.com., Bahri MH; Department of Surgery, School of Medicine, Alborz University of Medical Science, Karaj, Iran. Electronic address: m.bahri@abzums.ac.ir., Bozorgmehr R; Department of Surgery, School of Medicine, Alborz University of Medical Science, Karaj, Iran. Electronic address: r.bozorgmehr@abzums.ac.ir., Bagherpour JZ; Department of Surgery, School of Medicine, Alborz University of Medical Science, Karaj, Iran. Electronic address: javad.zebarjady@yahoo.com., Ziaie S; Internal Medicine, Independent Practice, Tehran, Iran. Electronic address: shirinziaie1992@gmail.com.

Journal Article , 2025

Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.

van der Wilk BJ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands. Electronic address: b.vanderwilk@erasmusmc.nl., Eyck BM; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., Wijnhoven BPL; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., Lagarde SM; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., Rosman C; Department of Surgery, Radboud University Medical Centre, Nijmegen, Netherlands., Noordman BJ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., Valkema MJ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., Bisseling TM; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, Netherlands., Coene PLO; Department of Surgery, Maasstad Hospital, Rotterdam, Netherlands., van Det MJ; Department of Surgery, ZGT Hospital, Almelo, Netherlands., Dekker JWT; Department of Surgery, Reinier de Graaf Gasthuis, Delft, Netherlands., van Dieren JM; Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Doukas M; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., van Esser S; Department of Surgery, Reinier de Graaf Gasthuis, Delft, Netherlands., Fiets WE; Department of Medical Oncology, Medical Centre Leeuwarden, Leeuwarden, Netherlands., Hartgrink HH; Department of Surgery, Leiden University Medical Centre, Leiden, Netherlands., Heisterkamp J; Department of Surgery, Elisabeth Tweesteden Hospital, Tilburg, Netherlands., Holster IL; Department of Gastroenterology, Maasstad Hospital, Rotterdam, Netherlands., Klarenbeek B; Department of Surgery, Radboud University Medical Centre, Nijmegen, Netherlands., van Klaveren D; Department of Public Health, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., Kouw E; Department of Gastroenterology and Hepatology, Gelre Hospital, Apeldoorn, Netherlands., Kouwenhoven EA; Department of Surgery, ZGT Hospital, Almelo, Netherlands., Luyer MD; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands., Oostenbrug LE; Department of Gastroenterology and Hepatology, Heerlen, Netherlands., Pierie JP; Department of Surgery, Medical Centre Leeuwarden, Leeuwarden, Netherlands., van Sandick JW; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Sosef MN; Department of Surgery, Zuyderland Medical Centre, Heerlen, Netherlands., Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., Valkema R; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands., van der Zaag ES; Department of Surgery, Gelre Hospital, Apeldoorn, Netherlands., Steyerberg EW; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands., van Lanschot JJB; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, Netherlands.

SANO Study Group

Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial , 2025

Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study.

Olthof EP; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Gynecological Oncology, Amsterdam University Medical Center, Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam, The Netherlands. e.olthof@iknl.nl., Wenzel HHB; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., van Maaren MC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., van der Velden J; Department of Gynecological Oncology, Amsterdam University Medical Center, Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam, The Netherlands., Spijkerboer AM; Department of Radiology, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Bekkers RLM; Department of Obstetrics and Gynecology, Catharina Hospital, Eindhoven, The Netherlands.; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Obstetrics and Gynecology, Medical Center and GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Beltman JJ; Department of Gynecology, Leiden University Medical Center, Leiden, The Netherlands., Slangen BFM; Department of Obstetrics and Gynecology, Medical Center and GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Nijman HW; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Smolders RGV; Department of Gynecological Oncology, Erasmus MC Cancer Institute University Medical Center, Rotterdam, The Netherlands., van Trommel NE; Center for Gynecologic Oncology Amsterdam (CGOA), The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Zusterzeel PLM; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., Zweemer RP; Department of Gynecological Oncology, University Medical Centre Utrecht, Utrecht Cancer Centre, Utrecht, The Netherlands., Stalpers LJA; Department of Radiation Oncology, Amsterdam University Medical Centre, Amsterdam, The Netherlands., van der Aa MA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Mom CH; Department of Gynecological Oncology, Amsterdam University Medical Center, Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam, The Netherlands.

Journal Article; Comparative Study , 2025

Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study.

Liu D; Department of Radiation Therapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, No. 150 Dongfang Road, Qiantang District, Hangzhou, Zhejiang 310018, P.R. China., Liang HW; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Qingxiu District, Nanning, Guangxi 530021, P.R. China., Liu Y; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Qingxiu District, Nanning, Guangxi 530021, P.R. China., Huang W; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Qingxiu District, Nanning, Guangxi 530021, P.R. China., Pan XB; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Qingxiu District, Nanning, Guangxi 530021, P.R. China.

Journal Article; Comparative Study , 2025

Neoadjuvant chemoradiation therapy application in radical esophagectomy surgery: Safety and feasibility: A descriptive study in Vietnam.

Nguyen ATT; Oncology Department, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.; Thoracic and Abdominal Department, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam., Dang THQ; Thoracic and Abdominal Department, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam., Dang SN; Thoracic and Abdominal Department, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam., Tran TC; Oncology Department, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam., Doan NT; Thoracic and Abdominal Department, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam., Nguyen VQ; Oncology Department, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam., Pham CH; Oncology Department, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.

Journal Article; Observational Study , 2025

Osteosarcopenia as a Predictor of Histopathologic Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer: a Retrospective Cohort Study.

Hirase Y; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Sasaki K; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan. k-sasaki@m.kufm.kagoshima-u.ac.jp., Tsuruda Y; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Shimonosono M; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Uchikado Y; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Matsushita D; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Arigami T; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Tada N; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Baba K; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Kawasaki Y; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan., Ohtsuka T; Department of Digestive Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima-shi, 890-8520, Japan.

Journal Article , 2025

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy.

Cabrit N; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Cheugoua-Zanetsie M; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France; Biostatistics and Epidemiology Office, Gustave Roussy, Villejuif, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Tierney J; MRC Clinical trial Unit at UCL, London, United Kingdom; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Thirion P; St Luke's Radiation Oncology Network Dublin, Trinity College Dublin, Ireland; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Nankivell M; MRC Clinical trial Unit at UCL, London, United Kingdom; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Winter K; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Yang H; Sun Yat-Sen University Cancer Center, Guangzhou, China; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Wijnhoven B; Erasmus University Medical Center, Rotterdam, the Netherlands; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Vernerey D; CHRU Jean Minjoz, Besançon, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Smithers BM; University of Queensland, Princess Alexandra Hospital, Australia; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Piessen G; Univ. Lille, CNRS, Inserm, Chu Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille F-59000, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Nilsson M; Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Boonstra J; Leiden University Medical Center, Leiden, the Netherlands; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Ychou M; Val d'Aurelles, Montpellier, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Law S; Department of Surgery, School of Clinical Medicine, The University of Hong Kong, Hong Kong; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Cunningham D; National Institute for Health Research, Biomedical Research Centres, Royal Marsden, London, UK; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Vathaire F; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Stahl M; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; Evang, Kliniken Essen-Mitte, Essen, Germany., Urba S; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; University of Michigan, Ann Arbor, USA., Valmasoni M; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; Padova University Hospital, Center for Esophageal Diseases, Department of Surgery, Oncology and Gastroenterology, Padova, Italy., Williaume D; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; Centre Eugène Marquis, Rennes, France., Thomas J; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; Princess Alexandra Hospital, Woolloongabba, Australia., Lordick F; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; Department of Oncology, University of Leipzig Medical Center, Leipzig, Germany., Tepper J; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; University of North Carolina School of Medicine, Chapel Hill, USA., Gebski V; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; NHMRC, Sydney, Australia., Burmeister B; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; Padova University Hospital, Center for Esophageal Diseases, Department of Surgery, Oncology and Gastroenterology, Padova, Italy., Paoletti X; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; Institut Curie, Paris, France., Sandick JV; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Fu J; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Pignon JP; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France; Biostatistics and Epidemiology Office, Gustave Roussy, Villejuif, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Ducreux M; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France; University Paris-Saclay, Medical Oncology Department, Gustave Roussy, France., Faron M; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France., Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France; Biostatistics and Epidemiology Office, Gustave Roussy, Villejuif, France; CESP U1018, Inserm, Université Paris-Saclay, Villejuif, France. Electronic address: stefan.michiels@gustaveroussy.fr.

MANATEC-02 collaborative group

Journal Article; Meta-Analysis , 2025

Long-Term Outcomes in Patients With Locally Advanced Rectal Cancer Following R1 Resection After Either Induction Chemotherapy and Chemoradiotherapy or Chemoradiotherapy Alone.

Hein Nordvig E; Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark. Electronic address: ellen.hein.frederiksen@regionh.dk., Bergliot Grønbæk GM; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Khalid Al-Uboody Z; Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark., Lykke J; Department of Gastrointestinal Surgery, Herlev and Gentofte Hospital, Herlev, Denmark., Hagen Vasehus Schou J; Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark., Østergaard Poulsen L; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.

Journal Article , 2025

Omission of Chemoradiation in Locally Advanced Rectal Adenocarcinoma: Evaluation of PROSPECT in a National Database.

Buchheit JT; Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Janczewski LM; Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Wells A; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Hardy AN; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Abad JD; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Bentrem DJ; Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, USA., Halverson AL; Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Chawla A; Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, USA.

Journal Article , 2024

Comparison of esophageal cancer survival after neoadjuvant chemoradiotherapy plus surgery versus definitive chemoradiotherapy: A systematic review and meta-analysis.

Ke J; Department of Thoracic Surgery, Gaozhou People's Hospital Affiliated to Guangdong Medical University, Maoming, China., Xie Y; Department of Thoracic Surgery, Gaozhou People's Hospital Affiliated to Guangdong Medical University, Maoming, China., Huang S; Department of Cardiothoracic Surgery, Guangdong Medical University, Zhanjiang, China., Wang W; Graduate School of Guangdong Medical University, Zhanjiang, China., Zhao Z; Department of Cardiothoracic Surgery, Guangdong Medical University, Zhanjiang, China., Lin W; Department of Thoracic Surgery, Gaozhou People's Hospital Affiliated to Guangdong Medical University, Maoming, China. Electronic address: wanliLin2020@163.com.

Systematic Review; Journal Article; Meta-Analysis; Comparative Study; Review , 2024

[A 5-year follow-up of the RAPIDO trial: Back to the future of long-course radiochemotherapy in total neoadjuvant treatment (TNT) for locally advanced rectal cancer?]

Edelmann M; Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland.; Göttingen Comprehensive Cancer Center (G-CCC), University Medical Center Göttingen, Von-Bar-Str. 2/4, 37075, Göttingen, Deutschland., Rieken S; Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland.; Göttingen Comprehensive Cancer Center (G-CCC), University Medical Center Göttingen, Von-Bar-Str. 2/4, 37075, Göttingen, Deutschland., Dröge LH; Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland. Hendrik.droege@med.uni-goettingen.de.; Göttingen Comprehensive Cancer Center (G-CCC), University Medical Center Göttingen, Von-Bar-Str. 2/4, 37075, Göttingen, Deutschland. Hendrik.droege@med.uni-goettingen.de.

Journal Article , 2024

Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.

Lee YD; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea.; Department of Medicine, Kyung Hee University College of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., Kim HG; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., Seo M; Department of Medicine, Kyung Hee University College of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., Moon SK; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., Park SJ; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea., You MW; Department of Radiology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, #23 Kyungheedae-ro, Dongdaemun-gu, 02447, Seoul, Republic of Korea. funfun2020@khu.ac.kr.

Journal Article , 2024

Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centres.

van den Berg K; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands. Electronic address: kim.vd.berg@catharinaziekenhuis.nl., Banken E; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., van Rees JM; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, University Hospital Rotterdam, the Netherlands., Coolen LM; Department of Radiology, Catharina Hospital, Eindhoven, the Netherlands., de Vries M; Department of Radiology, Erasmus MC Cancer Institute, University Hospital Rotterdam, the Netherlands., Voogt ELK; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Rothbarth J; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, University Hospital Rotterdam, the Netherlands., Rutten HJT; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Nederend J; Department of Radiology, Catharina Hospital, Eindhoven, the Netherlands., van Hellemond IEG; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Creemers GJM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Verhoef C; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, University Hospital Rotterdam, the Netherlands., Burger JWA; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.

Journal Article; Comparative Study , 2025

Complete pathological response to neoadjuvant chemoradiotherapy is associated with improved long-term survival after surgical treatment for rectal cancer.

Khajeh E; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany., Fakour S; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany., Zeh-Ressel C; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany., Jafari M; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany., Nikbakhsh R; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany., Ramouz A; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany., Mehrabi A; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany. Electronic address: arianeb.mehrabi@med.uni-heidelberg.de., Büchler MW; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany., Kulu Y; Department of General, Visceral, and Transplantation Surgery, Ruprecht-Karls University, Heidelberg, Germany; Center for General and Visceral Surgery, SLK-Clinics GmbH, Heilbronn, Germany.

Journal Article , 2025

Improved local control and survival outcomes with RADPLAT in T4 oropharyngeal cancer: a retrospective study.

Kano S; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-Ku, Sapporo, 060-8638, Japan. skano@med.hokudai.ac.jp., Suzuki T; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-Ku, Sapporo, 060-8638, Japan., Yoshida D; Diagnostic Imaging Center, Sapporo Yamanoue Hospital, Sapporo, Japan., Tsushima N; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-Ku, Sapporo, 060-8638, Japan., Idogawa H; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-Ku, Sapporo, 060-8638, Japan., Katsumata R; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-Ku, Sapporo, 060-8638, Japan., Yasuda K; Department of Radiation Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Kinota N; Department of Diagnostic Imaging, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Yamasaki K; Department of Diagnostic Imaging, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Shimizu Y; Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Taguchi J; Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Aoyama H; Department of Radiation Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Homma A; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-Ku, Sapporo, 060-8638, Japan.

Journal Article , 2025

Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients.

Xu J; Departerment of Oncology, Gaoxin Branch of the First Affiliated Hospital of Nanchang University, No. 7889 Changdong Avenue, High-tech Zone, Nanchang, 330000, Jiangxi, China., Ji Q; Department of Radiation Oncology, Nanchang People's Hospital, Nanchang, 330000, Jiangxi, China., Deng J; Departerment of Oncology, Gaoxin Branch of the First Affiliated Hospital of Nanchang University, No. 7889 Changdong Avenue, High-tech Zone, Nanchang, 330000, Jiangxi, China., Yu F; Departerment of Oncology, Gaoxin Branch of the First Affiliated Hospital of Nanchang University, No. 7889 Changdong Avenue, High-tech Zone, Nanchang, 330000, Jiangxi, China. fengyuncdc@21cn.com.

Journal Article; Comparative Study , 2025

Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.

Eminowicz G; University College Hospital NHS Trust, London, UK. Electronic address: gemmaeminowicz@nhs.net., Vaja S; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK., Gallardo D; Instituto Nacional de Cancerlogia, Mexico City, Mexico., Kent C; University of Leicester NHS Trust, UK., Panades M; United Lincolnshire Hospitals NHS Trust, UK., Mathew T; Sheffield Teaching Hospitals NHS Trust, UK., Anand A; Nottingham University NHS Trust, UK., Forrest J; Royal Devon University Hospitals NHS Foundation Trust, UK., Adusumalli M; South Tees Hospitals NHS Foundation Trust, UK., Chan A; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK., Hacker AM; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK., Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK., Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK., McCormack M; University College Hospital NHS Trust, London, UK.

Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial , 2025

Concurrent immunotherapy improves progression-free survival but increases toxicity in unresectable stage III NSCLC.

Qin Y; Department of Radiation Oncology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, People's Republic of China; Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, People's Republic of China., Mo Y; Department of Cardiovascular Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou University, Shantou, Guangdong 515000, People's Republic of China., Li P; Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, People's Republic of China., Liang X; Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, People's Republic of China; School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong 261000, People's Republic of China., Yu J; Department of Radiation Oncology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, People's Republic of China; Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, People's Republic of China. Electronic address: sdyujinming@126.com., Chen D; Department of Radiation Oncology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, People's Republic of China; Department of Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, People's Republic of China. Electronic address: dave0505@yeah.net.

Journal Article; Meta-Analysis , 2025

Predicting the incidence of hematologic toxicity in concurrent chemoradiotherapy for cervical cancer using pelvic MRI imaging.

Ke X; Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, Anhui, China., Zang C, Wu A, Liu Y

Journal Article , 2025